Recombinant

Type: Keyphrase
Name: Recombinant
First reported 14 hours ago - Updated 54 mins ago - 2 reports

Roche Introduces New Fertility Test

Swiss diagnostics maker Roche said Thursday it has launched the Elecsys Anti-Müllerian Hormone fertility test in all countries accepting the CE mark.The AMH blood test can be performed during any day of the menstrual cycle, providing superior results ... [Published FDA News - 3 hours ago]
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway

by Xiaoming Xu, Wei Mao, Qian Chen, Qin Zhuang, Lihui Wang, Jin Dai, Haibing Wang, Zhaoquan HuangEndostar, a novel modified recombinant human endostatin, is now widely studied for the treatment of diseases that are characterized or caused by pathological ... [Published Plosone.org - 5 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

A Universal Approach to Prepare Reagents for DNA-Assisted Protein Analysis

by Junhong Yan, Gucci Jijuan Gu, Christian Jost, Maria Hammond, Andreas Plückthun, Ulf Landegren, Masood Kamali-MoghaddamThe quality of DNA-labeled affinity probes is critical in DNA-assisted protein analyses, such as proximity ligation and extension ... [Published Plosone.org - 9 hours ago]
Entities: Protein, Reagent, Assay
First reported 18 hours ago - Updated 18 hours ago - 3 reports

Research and Markets: Recombinant Therapeutic Proteins Market & Pipeline Analysis 2014

Research and Markets ( http://www.researchandmarkets.com/research/tjb2xg/recombinant ) has announced the addition of the "Recombinant Therapeutic Proteins Market & Pipeline Analysis" report to their offering.Click to Continue » ... [Published Fort Mills Times - 18 hours ago]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Baxter Gets FDA Approval for RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B

Baxter International said that the United States Food and Drug Administration (FDA) has approved RIXUBIS [Coagulation Factor IX (Recombinant)] for routine prophylactic treatment, control and prevention of bleeding episodes, and perioperative management ... [Published Individual.com - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Patent Application Titled "Pharmaceutical Preparation Comprising Recombinant HcG" Published Online

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors Cottingham , Ian (St. Prex, CH); Plaksin, Daniel (St. Prex, CH); ... [Published 4 Traders - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Researchers from Genentech, Inc. Describe Findings in Immunoglobulins (Combined Administration of RG7652, a Recombinant Human Monoclonal Antibody...

Researchers from Genentech, Inc. Describe Findings in Immunoglobulins ( Combined Administration of RG7652 , a Recombinant Human Monoclonal Antibody Against PCSK9, and Atorvastatin Does Not Result in Reduction of Immune Function) (Combined ...)By a News ... [Published 4 Traders - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Patent Application Titled "Encapsulated Kidney Tissue" Published Online

By a News Reporter-Staff News Editor at Gene Therapy Weekly -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors Buensucceso, Charito S. ( North Brunswick, NJ ); Colter, David ... [Published HispanicBusiness.com - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

RECOTHROM (Thrombin Topical Recombinant) Kit [The Medicines Company]

First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine

by Mookkan Prabakaran, Sonja Leyrer, Fang He, Sebastian Auer, Subaschandrabose R. Kumar, Kathrin Kindsmueller, Nutan Mytle, Joerg Schneider, Stephen Lockhart, Jimmy KwangBackgroundThe rapid evolution of new sublineages of H5N1 influenza poses the greatest ... [Published Plosone.org - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C.

WHIPPANY, N.J."With posters that display research into treatment modalities in hemophilia A patients, Bayer is maintaining its commitment to research in bleeding disorders," said Dario MirskiNotable poster presentations will be displayed in Washington ... [Published Bio-Medicine - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Novel norovirus recombinants detected in South Africa

Noroviruses (NoV) are the leading cause of viral gastroenteritis worldwide. Recombination frequently occurs within and between NoV genotypes and recombinants have been implicated in sporadic cases, outbreaks and pandemics of NoV.There is a lack of data ... [Published 7thSpace - Sep 17 2014]

Quotes

(Date:9/18/2014)... Sept. 18, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 ... Acid Industry" and "2014 Deep Research Report on ... its research database."
"It is an important example of our focus on improving diagnostics in the area of women's health" Diggelmann added
Dr. Daniel Teper, Chairman and CEO of Immune comments:  "Bertilimumab is among the first biologic drugs for auto-immune diseases with a biomarker strategy.  We look forward to the results of this Phase II proof of concept clinical trial in Ulcerative Colitis as well as the previously initiated Phase II clinical trial in Bullous Pemphigoid, an orphan auto-immune disease of the skin."
Research and Markets (http://www.researchandmarkets.com/research/rrcznt/global_veterinary) has announced the addition of the "Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019" report to their offering. The global market for veterinary vaccines is estimated to be worth $12...

More Content

All (1320) | News (960) | Reports (0) | Blogs (310) | Audio/Video (0) | Fact Sheets (14) | Press Releases (30)
sort by: Date | Relevance
Roche Introduces New Fertility Test [Published FDA News - 3 hours ago]
Endostar, a Modified Recombinant Human Endostat... [Published Plosone.org - 5 hours ago]
Protect yourself: Get a flu shot now [Published Tampa Bay Times - 7 hours ago]
West Coast Biotech Roundup: Halozyme, Nektar, A... [Published Xconomy - 8 hours ago]
Microplastic pollution discovered in St. Lawren... [Published Bio-Medicine - 8 hours ago]
Bulldog Bio, Inc. Offered Exclusive Access To N... [Published BioSpace - 9 hours ago]
A Universal Approach to Prepare Reagents for DN... [Published Plosone.org - 9 hours ago]
Herpes Simplex Virus 1 (HSV-1) ICP22 Protein Di... [Published Plosone.org - 9 hours ago]
EMD Serono, Sutro Biopharma Form ADC Partnership [Published Bioresearch Online - 10 hours ago]
Geographic Separation of Domestic and Wild Stra... [Published Plosone.org - 11 hours ago]
A New Approach for Monitoring Ebolavirus in Wil... [Published Plosone.org - 11 hours ago]
Evaluation of Dried Blood Spots with a Multiple... [Published Plosone.org - 11 hours ago]
Transgenic Analysis of the Leishmania MAP Kinas... [Published Plosone.org - 11 hours ago]
Devangshu Datta: Lessons from the Ebola crisis [Published Business Standard India - 13 hours ago]
Roche unveils new fertility test for pregnancy [Published Medical Devices Business Review - 14 hours ago]
Immune Pharmaceuticals Initiates Phase II Clini... [Published PipelineReview - 14 hours ago]
U.S. Health Official's Testimony On U.S. Ebola ... [Published Individual.com - 14 hours ago]
Site-Specific Characterization of Glycosylation... [Published Future of BioPharma - 16 hours ago]
Halozyme Therapeutics : SWOG To Resume Trial In... [Published RTTNews.com - 16 hours ago]
Research and Markets: Recombinant Therapeutic P... [Published Fort Mills Times - 18 hours ago]
Research and Markets: Recombinant Therapeutic P... [Published Business Wire Health News - 18 hours ago]
Recombinant Therapeutic Proteins Market & Pipel... [Published Individual.com - 18 hours ago]
VENAXIS : University of California, Venaxis, Wa... [Published 4 Traders - 18 hours ago]
Immune begins bertilimumab Phase II clinical tr... [Published News-Medical.Net - 20 hours ago]
Global Veterinary Vaccines Market 2014-2019 - K... [Published Individual.com - 20 hours ago]
Bone Morphogenetic Protein Market – Research Re... [Published MyNewsDesk - 21 hours ago]
Baxter Gets FDA Approval for RIXUBIS [Coagulati... [Published Individual.com - Sep 18 2014]
Roche Bearer Share : introduces a new fertility... [Published 4 Traders - Sep 18 2014]
New research provides understanding that helps ... [Published Noodls - Sep 18 2014]
New Nanomaterials Findings from Center for Dise... [Published HispanicBusiness.com - Sep 18 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Site-Specific Characterization of Glycosylation... [Published Future of BioPharma - 16 hours ago]
Today, we feature an article from our partners at BioProcess International Magazine . This is an excerpt from the article Site-Specific Characterization of Glycosylation on Protein Drugs . Site-Specific Characterization of Glycosylation on Protein ...
Research and Markets: Recombinant Therapeutic P... [Published Business Wire Health News - 18 hours ago]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tjb2xg/recombinant) has announced the addition of the "Recombinant Therapeutic Proteins Market & Pipeline Analysis" report to their offering. There are many driving ...
RECOTHROM (Thrombin Topical Recombinant) Kit [T... [Published DailyMed Drug Label Updates for the last seven ... - Sep 17 2014]
Updated Date: Sep 17, 2014 EST ...
FDA Approves Baxter’s RIXUBIS [Coagulation Fact... [Published EON Consumer - Sep 15 2014]
DEERFIELD, Ill.--(EON: Enhanced Online News)--The United States FDA has approved Baxter's RIXUBIS for routine prophylactic treatment, control and prevention of bleeding episodes, and perioperative management in children with hemophilia B. ...
FDA Approves Baxter’s RIXUBIS [Coagulation Fact... [Published EON Science - Sep 15 2014]
DEERFIELD, Ill.--(EON: Enhanced Online News)--The United States FDA has approved Baxter's RIXUBIS for routine prophylactic treatment, control and prevention of bleeding episodes, and perioperative management in children with hemophilia B. ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Novavax Initiates Phase 2 Clinical Trial of RSV... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
Diamyd Medical and Protein Sciences deepen comm... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
Novavax to Host 2nd Annual Analyst and Investor... [Published GlobeNewswire: Acquisitions News - Sep 11 2014]
Versartis to Present at the Morgan Stanley 2014... [Published GlobeNewswire: Acquisitions News - Sep 02 2014]
Versartis Reports Second Quarter 2014 Financial... [Published GlobeNewswire: Acquisitions News - Aug 05 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.